Taiwan Resonant Waves Research Corp.

Taiwan Resonant Waves Research Corp. is rated 3 out of 5 in the category medical devices. Read and write reviews about Taiwan Resonant Waves Research Corp.. Taiwan Resonant Waves Research Corp. (TRWR) was founded in 2010 in the capital of Taiwan – Taipei. Integrating innovative bioelectronic technology with medical devices, we are dedicated to helping patients with chronic diseases better manage health-related challenges. Designed and developed by TRWR, Microcurrent Electrical Nerve Stimulation technology (MENS) is currently being used as a non-invasive, physical approach to treating and alleviating symptoms associated with diabetes mellitus. A randomized, double-blind, placebo-controlled trial of non-invasive T2DM-MENS device to improve blood glucose control in patients with type 2 diabetes is underway. The study is expected to be completed in 2019 and potentially become the world’s first non-invasive electronic medical device used to alleviate symptoms associated with type 2 diabetes. (https://clinicaltrials.gov/ct2/show/NCT03102424?term=Taiwan+Resonant&rank=1) There is unlimited promise in the application of bioelectronic technology in the treatment of chronic diseases. We are committed to addressing the unmet needs of those suffering from chronic diseases by pursuing advancements in bioelectronic technology and delivering cost-effective healthcare solutions.